Enterix

Enterix is a medical technology company specializing in the development and commercialization of non-invasive diagnostic tests for colorectal cancer and gastrointestinal disorders. The company is best known for its proprietary InSure Fecal Immunochemical Test (FIT), which utilizes liquid-based collection to detect human hemoglobin in stool samples. Unlike traditional guaiac-based tests, Enterix's technology does not require dietary or medication restrictions, significantly improving patient compliance and screening accuracy. In 2006, the company was acquired by Quest Diagnostics to enhance its portfolio of cancer screening and diagnostic services. The InSure product line remains a widely used standard for colorectal cancer screening in clinical practice.